Vascular checks will blow PBC budgets
I'm writing regarding the recommendations on vascular screening.
This is sensible - it's right to tackle health in populations rather than disease. However, we need to analyse the effect on the whole system. The more people we find with cardiovascular disease, the more medication will be used on them and the higher will be spending on medication.
But most practice-based commissioning groups are relying on reductions in medication spending to fund their PBC infrastructure. Vascular screening looks like a coup de gras, if not a nail in a coffin, for PBC, unless the rules are modified.
Dr Andrew Mimnagh, Waterloo, Merseyside